mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.09 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |